Literature DB >> 18672170

Noninvasive detection of macrophage-rich atherosclerotic plaque in hyperlipidemic rabbits using "positive contrast" magnetic resonance imaging.

Grigorios Korosoglou1, Robert G Weiss, Dorota A Kedziorek, Piotr Walczak, Wesley D Gilson, Michael Schär, David E Sosnovik, Dara L Kraitchman, Raymond C Boston, Jeff W M Bulte, Ralph Weissleder, Matthias Stuber.   

Abstract

OBJECTIVES: This study was designed to identify macrophage-rich atherosclerotic plaque noninvasively by imaging the tissue uptake of long-circulating superparamagnetic nanoparticles with a positive contrast off-resonance imaging sequence (inversion recovery with ON-resonant water suppression [IRON]).
BACKGROUND: The sudden rupture of macrophage-rich atherosclerotic plaques can trigger the formation of an occlusive thrombus in coronary vessels, resulting in acute myocardial infarction. Therefore, a noninvasive technique that can identify macrophage-rich plaques and thereby assist with risk stratification of patients with atherosclerosis would be of great potential clinical utility.
METHODS: Experiments were conducted on a clinical 3-T magnetic resonance imaging (MRI) scanner in 7 heritable hyperlipidemic and 4 control rabbits. Monocrystalline iron-oxide nanoparticles (MION)-47 were administrated intravenously (2 doses of 250 mumol Fe/kg), and animals underwent serial IRON-MRI before injection of the nanoparticles and serially after 1, 3, and 6 days.
RESULTS: After administration of MION-47, a striking signal enhancement was found in areas of plaque only in hyperlipidemic rabbits. The magnitude of enhancement on magnetic resonance images had a high correlation with the number of macrophages determined by histology (p < 0.001) and allowed for the detection of macrophage-rich plaque with high accuracy (area under the curve: 0.92, SE: 0.04, 95% confidence interval: 0.84 to 0.96, p < 0.001). No significant signal enhancement was measured in remote areas without plaque by histology and in control rabbits without atherosclerosis.
CONCLUSIONS: Using IRON-MRI in conjunction with superparamagnetic nanoparticles is a promising approach for the noninvasive evaluation of macrophage-rich, vulnerable plaques.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672170      PMCID: PMC2628468          DOI: 10.1016/j.jacc.2008.03.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  27 in total

1.  Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles.

Authors:  Patrick Wunderbaldinger; Lee Josephson; Ralph Weissleder
Journal:  Bioconjug Chem       Date:  2002 Mar-Apr       Impact factor: 4.774

2.  Passive tracking exploiting local signal conservation: the white marker phenomenon.

Authors:  Jan-Henry Seppenwoolde; Max A Viergever; Chris J G Bakker
Journal:  Magn Reson Med       Date:  2003-10       Impact factor: 4.668

3.  Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging.

Authors:  Jeff W M Bulte; Ali S Arbab; T Douglas; J A Frank
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

4.  Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.

Authors:  S G Ruehm; C Corot; P Vogt; S Kolb; J F Debatin
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

5.  Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits.

Authors:  K Ishikawa; D Sugawara; J Goto; Y Watanabe; K Kawamura; M Shiomi; H Itabe; Y Maruyama
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

6.  Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging.

Authors:  M E Kooi; V C Cappendijk; K B J M Cleutjens; A G H Kessels; P J E H M Kitslaar; M Borgers; P M Frederik; M J A P Daemen; J M A van Engelshoven
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

Review 7.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.

Authors:  René M Botnar; Arno Buecker; Andrea J Wiethoff; Edward C Parsons; Marcus Katoh; George Katsimaglis; Robert M Weisskoff; Randall B Lauffer; Philip B Graham; Rolf W Gunther; Warren J Manning; Elmar Spuentrup
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

9.  Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.

Authors:  Yoshimi Anzai; Catherine W Piccoli; Eric K Outwater; William Stanford; David A Bluemke; Pamela Nurenberg; Sanjay Saini; Kenneth R Maravilla; David E Feldman; Udo P Schmiedl; James A Brunberg; Isaac R Francis; Steven E Harms; Peter M Som; Clare M Tempany
Journal:  Radiology       Date:  2003-09       Impact factor: 11.105

10.  Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls.

Authors:  S A Schmitz; M Taupitz; S Wagner; S E Coupland; R Gust; A Nikolova; K J Wolf
Journal:  Invest Radiol       Date:  2002-07       Impact factor: 6.016

View more
  50 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

2.  A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imaging.

Authors:  Chih-Lung Chen; Haosen Zhang; Qing Ye; Wen-Yuan Hsieh; T Kevin Hitchens; Hsin-Hsin Shen; Li Liu; Yi-Jen Wu; Lesley M Foley; Shian-Jy Wang; Chien Ho
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

3.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

Review 4.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Authors:  Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

5.  T₁-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles.

Authors:  Longjiang Zhang; Xiaodong Zhong; Liya Wang; Hongwei Chen; Y Andrew Wang; Julie Yeh; Lily Yang; Hui Mao
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

6.  Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques.

Authors:  Ibrahim Aboshady; Dianna D Cody; Evan M Johnson; Amir Gahremanpour; Deborah Vela; Kamal G Khalil; Herbert L Dupont; James T Willerson; L Maximilian Buja; Gregory W Gladish
Journal:  Int J Cardiol       Date:  2010-12-24       Impact factor: 4.164

7.  Early identification of aortic valve sclerosis using iron oxide enhanced MRI.

Authors:  Amanda M Hamilton; Kem A Rogers; Andre J L Belisle; John A Ronald; Brian K Rutt; Ralph Weissleder; Derek R Boughner
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

8.  Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models.

Authors:  Liya Wang; Xiaodong Zhong; Weiping Qian; Jing Huang; Zehong Cao; Qiqi Yu; Malgorzata Lipowska; Run Lin; Andrew Wang; Lily Yang; Hui Mao
Journal:  J Magn Reson Imaging       Date:  2014-11       Impact factor: 4.813

9.  Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.

Authors:  David E Sosnovik; Peter Caravan
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-04-01

Review 10.  Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI part III.

Authors:  Bernard C M te Boekhorst; Maarten-Jan M Cramer; Gerard Pasterkamp; Cees J A van Echteld; Pieter A F M Doevendans
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.